TEDCO has invested $300,000 in Nanocrine, a biotechnology company that develops surfaces for studying living cells, to support their mission to revolutionize scientific research and enhance accuracy and reliability in various fields. Nanocrine's technology utilizes techniques from the semiconductor industry and physical chemistry disciplines to provide researchers with more precise measurements for quality control.
TEDCO Announces an SSBCI Investment into Nanocrine: Advancing the Scientific Research of Living Cells
TEDCO, Maryland's economic engine for technology companies, has announced a recent State Small Business Credit Initiative (SSBCI) investment of $300,000 into Nanocrine, a biotechnology company dedicated to creating a more efficient process for studying living cells. With this investment, TEDCO aims to support Nanocrine's mission to revolutionize the scientific research and exploration of living cells, ultimately enhancing the accuracy and reliability of research in various fields.
Nanocrine, based in Frederick, Maryland, has developed surfaces that utilize techniques from the semiconductor industry and physical chemistry disciplines to provide researchers with more precise measurements for quality control. By standardizing starting points, Nanocrine's technology has the potential to support researchers both within and outside of Maryland, advancing the scientific community's understanding of living cells.